Capital Advisory Group Advisory Services’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-3,250
| Closed | -$3.49M | – | 92 |
|
|
2025
Q4 | $3.49M | Sell |
3,250
-46
| -1% | -$44K | 1.03% | 24 |
|
|
2025
Q3 | $2.51M | Sell |
3,296
-3
| -0.1% | -$2.23K | 0.78% | 39 |
|
|
2025
Q2 | $2.57M | Sell |
3,299
-72
| -2% | -$55.9K | 0.92% | 34 |
|
|
2025
Q1 | $2.78M | Sell |
3,371
-35
| -1% | -$29.1K | 1.06% | 28 |
|
|
2024
Q4 | $2.63M | Sell |
3,406
-146
| -4% | -$121K | 0.94% | 32 |
|
|
2024
Q3 | $3.15M | Hold |
3,552
| – | – | 1.25% | 22 |
|
|
2024
Q2 | $3.22M | Sell |
3,552
-8
| -0.2% | -$6.4K | 1.37% | 16 |
|
|
2024
Q1 | $2.77M | Buy |
3,560
+150
| +4% | +$107K | 1.31% | 20 |
|
|
2023
Q4 | $1.99M | Sell |
3,410
-67
| -2% | -$39.1K | 1.07% | 27 |
|
|
2023
Q3 | $1.87M | Buy |
+3,477
| New | +$1.79M | 1.06% | 28 |
|
|
2023
Q2 | – | Sell |
-3,667
| Closed | -$1.26M | – | 115 |
|
|
2023
Q1 | $1.26M | Sell |
3,667
-9
| -0.2% | -$3.04K | 0.76% | 40 |
|
|
2022
Q4 | $1.34M | Sell |
3,676
-186
| -5% | -$65.9K | 0.91% | 35 |
|
|
2022
Q3 | $1.25M | Sell |
3,862
-78
| -2% | -$24.7K | 0.87% | 38 |
|
|
2022
Q2 | $1.13M | Sell |
3,940
-11
| -0.3% | -$3.3K | 0.67% | 43 |
|
|
2022
Q1 | $1.13M | Buy |
3,951
+65
| +2% | +$16.7K | 0.52% | 55 |
|
|
2021
Q4 | $1.07M | Buy |
3,886
+102
| +3% | +$25.9K | 0.47% | 62 |
|
|
2021
Q3 | $874K | Sell |
3,784
-579
| -13% | -$143K | 0.32% | 76 |
|
|
2021
Q2 | $1M | Buy |
4,363
+134
| +3% | +$26.9K | 0.36% | 70 |
|
|
2021
Q1 | $790K | Sell |
4,229
-70
| -2% | -$13.7K | 0.31% | 81 |
|
|
2020
Q4 | $726K | Buy |
4,299
+1,776
| +70% | +$265K | 0.3% | 78 |
|
|
2020
Q3 | $373K | Buy |
2,523
+988
| +64% | +$153K | 0.19% | 92 |
|
|
2020
Q2 | $252K | Hold |
1,535
| – | – | 0.14% | 108 |
|
|
2020
Q1 | $214K | Sell |
1,535
-200
| -12% | -$27.5K | 0.27% | 58 |
|
|
2019
Q4 | $226K | Hold |
1,735
| – | – | 0.12% | 95 |
|
|
2019
Q3 | $193K | Hold |
1,735
| – | – | 0.13% | 72 |
|
|
2019
Q2 | $192K | Hold |
1,735
| – | – | 0.13% | 76 |
|
|
2019
Q1 | $225K | Sell |
1,735
-400
| -19% | -$48.6K | 0.16% | 70 |
|
|
2018
Q4 | $246K | Sell |
2,135
-305
| -13% | -$34.1K | 0.19% | 58 |
|
|
2018
Q3 | $258K | Sell |
2,440
-450
| -16% | -$45K | 0.17% | 68 |
|
|
2018
Q2 | $248K | Sell |
2,890
-50
| -2% | -$4.11K | 0.18% | 65 |
|
|
2018
Q1 | $225K | Buy |
+2,940
| New | +$237K | 0.16% | 71 |
|
Other funds holding LLY
VCM
VPM
Capital Advisory Group Advisory Services's LLY Position: Q1 2026 in Review
Capital Advisory Group Advisory Services sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 3,250 shares — an estimated $3.49M sold.
Capital Advisory Group Advisory Services first reported a position in LLY in Q1 2018 and held it in 31 quarters. The position peaked at $3.49M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Capital Advisory Group Advisory Services reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
- Capital Advisory Group Advisory Services sold 3,250 Eli Lilly shares in Q1 2026, an estimated $3.49M.
- Capital Advisory Group Advisory Services first reported a position in Eli Lilly in Q1 2018 and held it in 31 quarters.
- Capital Advisory Group Advisory Services's Eli Lilly position peaked at $3.49M in Q4 2025.
- 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Capital Advisory Group Advisory Services's 13F filing for Q1 2026, filed 15 Apr 2026.